Navigation Links
NeuIsys Announces Entrance into the Gastroenterology Market
Date:1/27/2010

GREENSBORO, N.C., Jan. 27 /PRNewswire/ -- NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.

Joining the NeuIsys family of Urology, Internal Medicine, General Surgery, Neurology, Orthopedic, and Neurosurgery practices, these GI groups add an additional dimension of patient care to the NeuIsys universe.  With last year's addition of virtual colonoscopy to the American Cancer Society's preferred method of screening for colon rectal cancer, the NeuViz 16 Multi-Slice CT is the ideal diagnostic tool to implement a program to broaden the detection of curable colon cancers.  The GI groups, located in Georgia, Texas, and California, selected NeuIsys because of its breadth of experience, its turn key service, and its focus on private practices.

"We are very proud to announce these leaders in gastroenterology have teamed with NeuIsys to bring advanced imaging technologies to their patients.  We expect that these clinicians will be much better prepared and equipped to directly diagnose Colorectal diseases, and provide more timely resolutions.  This is directly in keeping with our mission to bring imaging closer to the patient," states NeuIsys CEO, Kim Russell.

About NeuIsys

NeuIsys Imaging Systems Solutions, LLC, headquartered in Greensboro, North Carolina, is a leader in providing state-of-the-art CT and MR imaging systems to physician practices, community hospitals, and imaging centers. NeuIsys is an exclusive North American distributor for Neusoft® Medical Systems and markets an array of products including the NeuViz Dual and NeuViz 16 multi-slice CT systems, the SuperStar HD open MRI system, multi-modality advanced visualization workstations, image management solutions, digital x-ray, and ultrasound products. For more information, please visit www.neuisys.com or call 877.299.9052.

SOURCE NeuIsys

RELATED LINKS
http://www.neuisys.com

'/>"/>

SOURCE NeuIsys
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement
2. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
3. Perrigo Company Announces Quarterly Dividend
4. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study
7. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
8. Warner Chilcott Announces 2010 Financial Guidance Conference Call
9. Connectyx Announces MedFlash(R) Sixth Man Fan Promotion in Conjunction With Walgreens and The Orlando Magic
10. TOPICA Announces Participation in BioPartnering North America
11. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology:
(Date:4/26/2017)... , ... April 26, 2017 , ... RawTrition now brings ... way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients to ... cellular level because the body recognizes its raw form (unlike the synthetically made options ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, ... to announce that it has received 510(k) clearance from the U.S. Food & ... the MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
Breaking Medicine News(10 mins):